The global pharmacovigilance and drug safety software market is poised for substantial growth, with an expected value of USD 14.86 billion by the year 2030. Recent market analysis indicates that the market size for pharmacovigilance and drug safety software was valued at USD 6.83 billion in 2022, reflecting a robust upward trajectory with a Compound Annual Growth Rate (CAGR) of 10.2% over the...